APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,381,776 | +102.3% | 194,053 | +384.5% | 0.04% | +94.7% |
Q2 2023 | $3,648,828 | -82.6% | 40,053 | -87.4% | 0.02% | -83.6% |
Q1 2023 | $20,945,796 | -10.1% | 317,553 | -29.5% | 0.12% | -16.5% |
Q4 2022 | $23,290,184 | -28.7% | 450,400 | -5.8% | 0.14% | -23.2% |
Q3 2022 | $32,647,000 | -66.7% | 478,000 | -69.2% | 0.18% | -54.8% |
Q2 2021 | $97,960,000 | +5.0% | 1,550,000 | -28.7% | 0.40% | -13.8% |
Q1 2021 | $93,329,000 | -28.3% | 2,175,000 | -4.4% | 0.46% | -40.7% |
Q4 2020 | $130,130,000 | +89.6% | 2,275,000 | 0.0% | 0.78% | +64.8% |
Q3 2020 | $68,637,000 | -6.6% | 2,275,000 | +1.1% | 0.48% | -19.2% |
Q2 2020 | $73,485,000 | +37.2% | 2,250,000 | +12.5% | 0.59% | +27.8% |
Q1 2020 | $53,580,000 | +250.0% | 2,000,000 | +300.0% | 0.46% | +346.6% |
Q4 2019 | $15,310,000 | – | 500,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |